Response Genetics (PK) Stock Price

0.00 (0.0%)
Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Response Genetics Inc (PK) RGDXQ OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.0013 10:36:57
Close Price Low Price High Price Open Price Previous Close
0.0013 0.00165 0.00165 0.0013
Bid Price Ask Price Spread News
0.0013 0.002 0.0007 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3 8,037 $ 0.001519 $ 12 44,105 0.0003 - 0.0065
Last Trade Time Type Quantity Stock Price Currency
13:05:26 37 $ 0.00144 USD

Response Genetics (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 50.43k 38.80M 27.34M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
80.01k $ - 0.00% - -

more financials information »

Response Genetics (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RGDXQ Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00340.00340.00130.0014821165,328-0.0021-61.76%
1 Month0.00280.00340.00030.0017178121,607-0.0015-53.57%
3 Months0.00240.00380.00030.002245375,021-0.0011-45.83%
6 Months0.00240.00580.00030.0025044118,892-0.0011-45.83%
1 Year0.00370.00650.00030.0027446119,675-0.0024-64.86%
3 Years0.000750.00770.00010.0027324189,0710.0005573.33%
5 Years0.00610.0240.00010.0035973309,024-0.0048-78.69%

Response Genetics (PK) Description

Response develops, manufactures and markets rapid onsite diagnostic tests for use with its RAMP platform for clinical, biodefense and environmental applications. RAMP represents a unique paradigm in diagnostics that provides reliable, quality results in minutes. The RAMP platform consists of a reader and single use disposable test cartridges and has the potential to be adapted to any other medical and nonmedical immunoassay based test currently performed in laboratories. Response clinical tests are commercially available for the aid in early detection of heart attack, congestive heart failure, thromboembolism and infectious diseases. In the nonclinical market, RAMP tests are currently available for the environmental detection of West Nile Virus antigen and for Biodefense applications including the rapid onsite detection of anthrax, smallpox, ricin and botulinum toxin.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.